A strategy to differentiate the roles of hyperglycemia and insulin deficiency to diabetic complications is to separately restore insulin signaling in an affected tissue without effecting glucose exposure and to correct systemic hyperglycemia without increasing insulin levels. The gene discussed is INS; the disease is Hyperglycemia.